PATHOLOGICAL OUTCOME OF HER2/NEU-POSITIVE EARLY BREAST CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY. Frontier in Medical and Health Research, [S. l.], v. 3, n. 7, p. 1552–1558, 2025. Disponível em: https://fmhr.net/index.php/fmhr/article/view/1887.. Acesso em: 12 aug. 2026.